{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkPTU7qkIDA","lastupdate":"2023-12-21T00:00:00.000Z","update_date":"2023-12-21T00:00:00.000Z","lastModified":"May 3, 2024","active":1,"confidence_score":97,"confidence_score_reason":"video or image, markets","urlname":"mana-bio","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$phncbBv5kWmVXUrv4bL0YbNKxp4Jdj8S5UGXstaUTyJesWlG9RQ4TA","name":"Mana.bio","oneliner":"AI-based Programmable Drug Delivery","registrar":"516477247","website":"https://www.mana.bio/","careerspage":"https://www.mana.bio/jobs","founded_month":10,"founded_year":2021,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/76563098","instagram":""},"social":["https://www.linkedin.com/company/76563098"],"flattenedsociallinks":"https://www.linkedin.com/company/76563098","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":19,"patent":0,"raised":24500000,"stage":"Seed","public_stage":"Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["manabio","mana bio","Mana"],"about":"Mana.bio specializes in AI-based drug-delivery solutions, with a focus on gene therapy. The companys technology integrates machine learning and nanotechnology for the development of drug-delivery systems.\n\nMana.bio has created a platform for lipid nanoparticle development for oligonucleotide therapies, including mRNA-based therapeutics, vaccines, and gene therapy.\n\nThe technology is powered by an integration of machine learning and nanotechnology in order to identify formulations of lipid nanoparticles drug delivery systems.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"","country":null,"address":{"israeli":[{"id":"8c5a0e5e-ba2a-4a60-88e3-750f3322d7ee","city":"Haifa","type":null,"address":"Haifa, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null},{"id":"dbdeb4b6-e142-4dab-abb3-261d8bd1a840","city":"Tel Aviv-Yafo","type":null,"address":"Tel Aviv, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District,North District","news":[{"id":"hmcbvyL7uByPXNNhvQFYAplwl2PZZcNsJJ8Jiw7oZfasv3vmURXFbe","date":"Sep 17, 2025","link":"https://www.prnewswire.com/il/news-releases/manabio-unveils-minathe-worlds-first-large-language-model-powered-ai-agent-for-lipid-nanoparticles-302558304.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"AI, RNA","round":null,"company":"Mana.bio","layoffs":null,"summary":"Mana.bio, a biotechnology company, has launched Mina™, the first large language model specifically designed for lipid nanoparticles (LNPs). This AI-powered tool, described as a ChatGPT for LNPs, is publicly available for free and aims to accelerate scientific discovery in RNA delivery and therapeutics development. Mina provides predictive modeling, curated data retrieval, and formulation optimization to enhance research and innovation in gene therapy and RNA-based medicines. The launch of Mina represents a significant advancement in AI-driven platforms for scientific research, bridging the gap between laboratory research and clinical application. Mana.bio is committed to collaborating with partners to leverage Minas capabilities.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["AI","RNA","LNP","therapeutics","discovery"],"date_of_event":null,"product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Product Stage","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"eZAtsKdrniGyqySRg0fhyd3Q01UgcXT9Upq9rcg8sNoAWB2laFPSom","news_summary":"/PRNewswire/ -- Mana.bio, a biotechnology company pioneering the intersection of artificial intelligence and RNA delivery, today announced the launch of Mina™,...","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"WfzWfCNsSeNKpx8NHPI7l75RDgyw6Kx03RqePJ7NcW4iwvnjDV2uBh","date":"Dec 11, 2024","link":"https://www.prnewswire.com/il/news-releases/manabio-presents-broad-improvements-to-systemic-lipid-nanoparticle-tolerability-by-leveraging-a-novel-ai-driven-safety-model-302328811.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"AI-driven innovation","company":"Mana.bio","layoffs":null,"summary":"Mana.bio, a seed-stage biotech company, is pioneering the use of AI and ML to design lipid nanoparticles (LNP) for RNA therapeutics. At the 3rd annual LNP Immunogenicity & Toxicity Summit in Boston on December 10, 2024, Mana.bio presented data demonstrating significant advancements in their AI-driven LNP delivery platform. Their second-generation LNP candidate showed a 100-fold increase in in-vivo potency after three months of iterative development. The company is leveraging AI to expedite drug development, potentially reducing timelines by years. Mana.bios platform integrates public and proprietary data to train ML models, optimizing LNP for potency and safety. The company plans to attend the JP Morgan Healthcare conference in January 2024.","partners":[],"customers":[],"investors":[],"confidence":9,"key_topics":["AI","RNA","LNP","therapeutics","safety"],"date_of_event":"December 10, 2024","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"wnKIZgh3YpKShKeRiUSmXLiTgY2DmtPX7208IVJGxdNFxoekMRZmdt","news_summary":"/PRNewswire/ -- Mana.bio, a seed-stage biotech company pioneering the use of artificial intelligence (AI) and machine learning (ML) to design lipid...","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"NhdVKiU2H3pqyEqgiz3JNJ4VeXx6CbmbqA0HK0uVwQ20FSLvs1zpPY","date":"Oct 12, 2023","link":"https://www.calcalist.co.il/ctechnews/article/rjkyo2hzt","source":"www.calcalist.co.il","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"TulJaJnrchLzFsq3T8ezDAPJXHkj9Rnm0eYH05nu3i15bKaOzw0am5","news_summary":"Biotech startup Mana.bio raises $19.5 million Seed to accelerate programmable drug delivery | CTech","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"mPtEezfgbQFvYpMxJpSLw5Tle1pYlychuIMvegyV1KLdqQPDxdQfGS","date":"Oct 10, 2023","link":"https://endpts.com/exclusive-andreessen-horowitz-backed-mana-bio-launches-for-ai-designed-lipid-nanoparticles/","source":"endpts.com","visible":1,"analysis":{"tags":"Investment, Biotechnology","company":"Mana.bio","layoffs":"Not mentioned","summary":"Mana.bio, a new startup based in Tel Aviv, Israel, has raised $19.5 million in seed financing. The company aims to address one of the biggest challenges facing genetic medicines - delivering them to the right part of the body. The funding round was led by Andreessen Horowitz Bio + Health, Base4 Capital, NFX, LionBird, and Technion — Israel Institute of Technology.","partners":"Not mentioned","customers":"Not mentioned","investors":["Andreessen Horowitz Bio + Health","Base4 Capital","NFX","LionBird","Technion — Israel Institute of Technology"],"confidence":9,"key_topics":["Genetic Medicines","Seed Financing","Lipid Nanoparticles","Biotechnology","Start-up"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$19.5 million","structured_issues":["Investment"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"gkBAZPd8UEfszaDV75mZsVTHsDHpLs68aoYXSSdGcICNFWnOi3SvM6","news_summary":"Exclusive: Andreessen Horowitz-backed startup is using AI to design lipid nanoparticles that go beyond the liver","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":4,"techcommunityinvolvement":null,"mediagallery":[],"tags":["pharmaceuticals","machine-learning","nanotechnology","artificial-intelligence","genetics","drug-delivery","cell-therapy","therapeutics"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"R&D","products":["Mana.bio"],"geomarkets":[],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":5,"lastfunding":"$19.5M","totalrounds":2,"fundingstage":"Seed","totalfunding":"$24.5M","publicinvestors":5,"lastpublicfunding":19500000,"totalpublicrounds":1,"totalpublicfunding":19500000},"team":[{"name":"Yogev Debbi","email":"yogev@mana.bio","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkLSQsNwKDA","bounced":false,"claimed":0,"founder":1,"urlname":"yogev-debbi-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQjNCAlwsM","position":"Co-founder & CEO","last_name":"Debbi","claimtoken":"lExqXvRa9iMsUOdljghJokhXcH63RYdOuTO7Fg2o2NO3CYYJRVHjPD","first_name":"Yogev","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yogev-debbi-a100834/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-01-03 13:52:50.000000","initials":"YD","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Roy Nevo","email":"roynevo@gmail.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGytLAIDA","bounced":false,"claimed":1,"founder":1,"urlname":"roy-nevo","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQ1JGdiwkM","position":"Co-founder & CTO","last_name":"Nevo","claimtoken":"6d69d4058fa875febb846ed231c74487f124766bf0a2efdad4a1e906c7befd04","first_name":"Roy","picturekey":"$A0DWpTYWPY5hSjCrdy0Cbqjd19797YXrQ0yViBNJ6yAzRz9J2DtkWJ","claimeddate":"2022-06-07","linkedinurl":"https://www.linkedin.com/pub/roy-nevo/3/b0b/a09","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-06-07 08:47:38.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$A0DWpTYWPY5hSjCrdy0Cbqjd19797YXrQ0yViBNJ6yAzRz9J2DtkWJ","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNqyo8cLDA","fullname":"Yotam Maman"},"biverifydate":"2022-04-11T00:00:00.000Z","crunchbaseid":"","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Matan Eblagon","creator_email":"matane@sncentral.org","createdate":"2022-03-17T00:00:00.000Z","biverification":"Yotam Maman","sectorverification":null,"affiliatedOrganizations":null,"timeline":[{"id":"tZDFpsulJzDdgl87XVQmSzLVtGlTLHvzSg6g1kFBYGelRhVUpw8XeA","date":"Oct 2023","amount":"$19.5M","source":"https://endpts.com/exclusive-andreessen-horowitz-backed-mana-bio-launches-for-ai-designed-lipid-nanoparticles/","eventtype":"FundingRoundEvent","investment":[{"name":"LionBird","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/lionbird","logokey":"$WaMmvlTjCIiqB4kYWzcKNrlzX5jIQtIy1HEoNpA1BUcbfxxlQK1K83","tagline":null,"urlname":"/investor_page/lionbird","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP6Hw4AKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"3VQgPLY53a5fQvryw85Q2d71eUErvqsAfTq1WtKz2SPZj8hf3Z5Sr0","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$WaMmvlTjCIiqB4kYWzcKNrlzX5jIQtIy1HEoNpA1BUcbfxxlQK1K83","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Technion Research & Development Foundation","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/technion-research-development-foundation-1","logokey":"$WT57F82oZhvXUSEZQMsR8SciiZH0nqkygmIGb4cR4s4KhZgsnECXaw.jpeg","tagline":"","urlname":"/investor_page/technion-research-development-foundation-1","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE7qW2CQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"93Cpcs2ZDTGEw44tq97V6fViIJ3htQmpgHaeNqXzfadVHU00ulrLer","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$WT57F82oZhvXUSEZQMsR8SciiZH0nqkygmIGb4cR4s4KhZgsnECXaw.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Base4 Capital","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/base4-capital","logokey":null,"tagline":"Long-Short Equity Hedge Fund Manager","urlname":"/investor_page/base4-capital","isisraeli":null,"investorid":"XZ5jGhdDJdYynrSKrYXkonvZC9e8UqYiZd09FXzeHwMOLcC6wYGnY6","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"VMxRjtYf1Brcg7F5pUai9VZaTwn9GRyVsXQuSmc7tMXmYINtWzWz4e","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Andreessen Horowitz","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/andreessen-horowitz","logokey":"$qyX7Z7qDiyJaAound8LJinpuCmEMW2FL1IZ3wIFxbAdeab3tc4ASqR","tagline":null,"urlname":"/investor_page/andreessen-horowitz","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NX2o4YKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"i9q3wS4MI2KS8YstT8CR3Gsi6ytjaSSWeRuCY7yAzKTn6R6dGZv16e","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$qyX7Z7qDiyJaAound8LJinpuCmEMW2FL1IZ3wIFxbAdeab3tc4ASqR","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"NFX Capital","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/nfx-guild1","logokey":"$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","tagline":null,"urlname":"/investor_page/nfx-guild1","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KTEh9IIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"zBMZmrYZYIx892nep3tCgHLkZFBlkrAAa49RrJMwLN2Gf1dgRcRu9w","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":19500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCMwcebCgw","date":"Oct 2021","amount":"$5M","source":"https://www.tech12.co.il/index-investments/Artichttps://www.linkedin.com/in/omri-amirav-drory-50572727/, From: SNC <finder@sncentral.org>  Sent: Tuesday, 7 June 2022 10:20 To: Yotam Maman <yotam.maman@sncentral.org> Subject: Edit Company Suggestion from Roy Nevo  User Name: Roy Nevo User Email: roynevo@gmail.com Company Name: Mana.bio Message: Please add LionBird as our second investor at Mana.bio","eventtype":"FundingRoundEvent","investment":[{"name":"NFX Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/nfx-guild1","logokey":"$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","tagline":null,"urlname":"/investor_page/nfx-guild1","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KTEh9IIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"0b9b6d85-9da1-46c9-be92-a13863a79a81","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","leadcaption":"","followupcaption":""},{"name":"LionBird","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/lionbird","logokey":"$WaMmvlTjCIiqB4kYWzcKNrlzX5jIQtIy1HEoNpA1BUcbfxxlQK1K83","tagline":null,"urlname":"/investor_page/lionbird","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP6Hw4AKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"f4b9e9cf-4b2d-43fe-b642-eb04672d8b32","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$WaMmvlTjCIiqB4kYWzcKNrlzX5jIQtIy1HEoNpA1BUcbfxxlQK1K83","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Private","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"10/2021","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Mana.bio","logourl":"https://storage.googleapis.com/clean-finder-353810/$phncbBv5kWmVXUrv4bL0YbNKxp4Jdj8S5UGXstaUTyJesWlG9RQ4TA","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$phncbBv5kWmVXUrv4bL0YbNKxp4Jdj8S5UGXstaUTyJesWlG9RQ4TA","seoabout":"Mana.bio specializes in AI-based drug-delivery solutions, with a focus on gene therapy. The companys technology integrates machine learning and nanotechnol...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":2,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drug Delivery","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA>Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drug Delivery#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drug Delivery#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|2:>TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA/Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drug Delivery","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drug Delivery"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Biotechnology","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Biotechnology"}]}]}],"coreTechnology":[{"title":"Artificial Intelligence","key":"0-0","path":"TechnologyClassificationModel>Artificial Intelligence","children":[{"title":"Machine Learning","key":"0-0-0","path":"TechnologyClassificationModel>Artificial Intelligence>Machine Learning"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drug Delivery","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drug Delivery"],"coreTechnology":["Artificial Intelligence","Machine Learning"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Biotechnology"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"tZDFpsulJzDdgl87XVQmSzLVtGlTLHvzSg6g1kFBYGelRhVUpw8XeA","date":"Oct 2023","amount":"$19.5M","source":"https://endpts.com/exclusive-andreessen-horowitz-backed-mana-bio-launches-for-ai-designed-lipid-nanoparticles/","eventtype":"FundingRoundEvent","investment":[{"name":"LionBird","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/lionbird","logokey":"$WaMmvlTjCIiqB4kYWzcKNrlzX5jIQtIy1HEoNpA1BUcbfxxlQK1K83","tagline":null,"urlname":"/investor_page/lionbird","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP6Hw4AKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"3VQgPLY53a5fQvryw85Q2d71eUErvqsAfTq1WtKz2SPZj8hf3Z5Sr0","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$WaMmvlTjCIiqB4kYWzcKNrlzX5jIQtIy1HEoNpA1BUcbfxxlQK1K83","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Technion Research & Development Foundation","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/technion-research-development-foundation-1","logokey":"$WT57F82oZhvXUSEZQMsR8SciiZH0nqkygmIGb4cR4s4KhZgsnECXaw.jpeg","tagline":"","urlname":"/investor_page/technion-research-development-foundation-1","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE7qW2CQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"93Cpcs2ZDTGEw44tq97V6fViIJ3htQmpgHaeNqXzfadVHU00ulrLer","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$WT57F82oZhvXUSEZQMsR8SciiZH0nqkygmIGb4cR4s4KhZgsnECXaw.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Base4 Capital","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/base4-capital","logokey":null,"tagline":"Long-Short Equity Hedge Fund Manager","urlname":"/investor_page/base4-capital","isisraeli":null,"investorid":"XZ5jGhdDJdYynrSKrYXkonvZC9e8UqYiZd09FXzeHwMOLcC6wYGnY6","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"VMxRjtYf1Brcg7F5pUai9VZaTwn9GRyVsXQuSmc7tMXmYINtWzWz4e","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Andreessen Horowitz","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/andreessen-horowitz","logokey":"$qyX7Z7qDiyJaAound8LJinpuCmEMW2FL1IZ3wIFxbAdeab3tc4ASqR","tagline":null,"urlname":"/investor_page/andreessen-horowitz","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NX2o4YKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"i9q3wS4MI2KS8YstT8CR3Gsi6ytjaSSWeRuCY7yAzKTn6R6dGZv16e","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$qyX7Z7qDiyJaAound8LJinpuCmEMW2FL1IZ3wIFxbAdeab3tc4ASqR","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"NFX Capital","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/nfx-guild1","logokey":"$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","tagline":null,"urlname":"/investor_page/nfx-guild1","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KTEh9IIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"zBMZmrYZYIx892nep3tCgHLkZFBlkrAAa49RrJMwLN2Gf1dgRcRu9w","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":19500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCMwcebCgw","date":"Oct 2021","amount":"$5M","source":"https://www.tech12.co.il/index-investments/Artichttps://www.linkedin.com/in/omri-amirav-drory-50572727/, From: SNC <finder@sncentral.org>  Sent: Tuesday, 7 June 2022 10:20 To: Yotam Maman <yotam.maman@sncentral.org> Subject: Edit Company Suggestion from Roy Nevo  User Name: Roy Nevo User Email: roynevo@gmail.com Company Name: Mana.bio Message: Please add LionBird as our second investor at Mana.bio","eventtype":"FundingRoundEvent","investment":[{"name":"NFX Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/nfx-guild1","logokey":"$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","tagline":null,"urlname":"/investor_page/nfx-guild1","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KTEh9IIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"0b9b6d85-9da1-46c9-be92-a13863a79a81","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","leadcaption":"","followupcaption":""},{"name":"LionBird","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/lionbird","logokey":"$WaMmvlTjCIiqB4kYWzcKNrlzX5jIQtIy1HEoNpA1BUcbfxxlQK1K83","tagline":null,"urlname":"/investor_page/lionbird","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP6Hw4AKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"f4b9e9cf-4b2d-43fe-b642-eb04672d8b32","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$WaMmvlTjCIiqB4kYWzcKNrlzX5jIQtIy1HEoNpA1BUcbfxxlQK1K83","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Private","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}